Potential cancer break-through treatment halted after two trial patients die

‘Trials of an experimental therapy to treat Leukemia have been halted by US authorities after two patients died last week. The treatment developed by Juno Therapeutics looks to reprogram cells to find and eliminate cancer.
The two patients who passed away died from swelling of the brain, which occurred after the chemotherapy agent fludarbine was added to the treatment program. Doctors began to see an increase in “severe neurotoxicity,” said CEO Hans Bishop.’
Read more: Potential cancer break-through treatment halted after two trial patients die